Syndromic Multiplex Diagnostics Market, By Type (Respiratory, astrointestinal, and Central Nervous System), By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Syndromic Multiplex Diagnostics Market size was valued at USD 2,889.76 Million in 2024, expanding at a CAGR of 4.2% from 2024 to 2032.
Syndromic multiplex diagnostics is an advanced testing approach that simultaneously detects multiple pathogens or biomarkers linked to a specific syndrome using a single test panel. Utilizing molecular techniques such as PCR, this method quickly identifies the causative agents behind illnesses with overlapping symptoms, including respiratory, gastrointestinal, and neurological infections. By targeting a broad range of pathogens in one assay, it improves diagnostic accuracy, shortens the time to treatment, and supports more informed clinical decision-making. This approach is especially valuable in settings where rapid identification of the infection source is critical, such as hospitals, emergency departments, and during outbreak investigations.
Syndromic Multiplex Diagnostics Market- Market Dynamics
Growing Demand for Fast and Precise Diagnostic Solutions
The increasing demand for rapid and accurate disease identification is a major driver of the syndromic multiplex diagnostics market. Traditional diagnostic methods, which often take longer and test for a single pathogen at a time, are being outpaced by syndromic panels that provide faster results and simultaneously detect multiple pathogens from a single sample. This capability is especially crucial for managing infectious disease outbreaks and critical care situations, where timely diagnosis can greatly improve patient outcomes. Additionally, the global emphasis on public health preparedness and antimicrobial stewardship further accelerates the adoption of these advanced diagnostic solutions. For instance, according to the World Health Organization (WHO), over 120 countries have implemented national strategies to enhance diagnostic capacities, supported by government funding and international collaborations, which significantly boost market growth worldwide.
Syndromic Multiplex Diagnostics Market- Segmentation Analysis:
The global Syndromic Multiplex Diagnostics Market is divided into Three categories: Type, End-user, and Region.
The syndromic multiplex diagnostics market is segmented by type into Respiratory, Gastrointestinal, Central Nervous System (CNS), and other syndromes such as complicated urinary tract infections (cUTIs) and sexually transmitted diseases (STDs). Among these, the Respiratory segment holds the dominant market share, driven largely by the high prevalence of respiratory infections, especially during seasonal flu outbreaks and global pandemics like COVID-19. The ability to rapidly identify multiple respiratory pathogens from a single patient sample significantly improves clinical efficiency and supports effective infection control measures. Increased awareness about the importance of early diagnosis, coupled with the growing adoption of syndromic multiplex panels in hospitals and point-of-care settings, continues to boost demand for respiratory multiplex diagnostic solutions. According to the U.S. Department of Health and Human Services (HHS), the use of multiplex respiratory panels in clinical diagnostics increased by over 40% following the COVID-19 pandemic, highlighting the critical role these tests play in managing respiratory infections.
By end use, the syndromic multiplex diagnostics market is divided into Hospitals, Diagnostic Laboratories, and Others, which include clinics, research institutes, and point-of-care settings. Hospitals represent the dominant segment due to their large patient volumes, urgent care needs, and access to advanced diagnostic technologies. Hospitals frequently manage complex cases that require rapid and comprehensive testing, which syndromic panels effectively provide. The integration of multiplex diagnostics into emergency departments and intensive care units enables timely clinical decision-making and improved patient outcomes, particularly during infectious disease outbreaks. Moreover, hospitals benefit from in-house laboratories staffed with trained personnel, which facilitates the widespread adoption of these technologies for critical syndromic testing applications. Data from the Centers for Medicare & Medicaid Services (CMS) indicates that over 65% of syndromic multiplex diagnostic tests are performed within hospital settings, emphasizing their pivotal role in this market segment.
Syndromic Multiplex Diagnostics Market- Geographical Insights
Geographically, the Syndromic Multiplex Diagnostics Market spans North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa, with regions further segmented by key contributing countries.
North America dominates the syndromic multiplex diagnostics market, driven by its advanced healthcare infrastructure, strong research and development capabilities, and early adoption of cutting-edge diagnostic technologies. The United States, in particular, leads the region due to substantial investments in molecular diagnostics and public health programs focused on enhancing early disease detection. According to the U.S. government, federal funding for infectious disease diagnostics increased by over 15% between 2022 and 2024, supporting initiatives to improve rapid testing capabilities. Widespread awareness of infectious diseases, robust government funding, and well-established reimbursement systems further bolster market growth. Additionally, the high prevalence of respiratory infections and chronic diseases, coupled with a comprehensive network of hospitals and diagnostic laboratories, solidifies North America’s leadership in the global market.
Europe is another prominent region in the syndromic multiplex diagnostics market, supported by growing demand for efficient diagnostic solutions and strong regulatory frameworks that encourage the adoption of advanced medical technologies. Leading countries such as Germany, the United Kingdom, and France benefit from modern healthcare systems and significant public health investments. The European Union allocated approximately €1.2 billion in 2023 toward infectious disease preparedness and diagnostic innovation, which has accelerated the adoption of multiplex panels in clinical practice. Furthermore, an aging population and rising rates of respiratory and gastrointestinal infections continue to drive demand. The region’s commitment to healthcare innovation establishes Europe as a key player in this market.
Syndromic Multiplex Diagnostics Market- Competitive Landscape:
The syndromic multiplex diagnostics market is shaped by both established industry leaders and innovative newcomers. Prominent players such as Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche, Qiagen, and bioMérieux dominate the market with comprehensive multiplex panels and cutting-edge molecular platforms. These companies invest heavily in research and development to improve test accuracy, shorten turnaround times, and broaden pathogen detection capabilities. Meanwhile, emerging entrants focus on rapid, point-of-care solutions to address niche market needs. Strategic collaborations, mergers, and acquisitions further reinforce market positions. This competitive landscape fosters ongoing innovation, enhancing diagnostic performance and enabling timely, effective patient care worldwide.
Recent Developments:
- In March 2025, Abbott launched a rapid multiplex respiratory panel that delivers results in under 30 minutes, significantly improving early diagnosis and treatment in clinical settings.
- In January 2024, Thermo Fisher expanded its syndromic testing portfolio by acquiring a molecular diagnostics company specializing in automated PCR technologies, thereby extending its market reach.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd
- Qiagen
- Biomérieux
- Diasorin S.P.A (Luminex Corporation)
- Hologic, Inc.
- Becton, Dickinson And Company (Bd)
- Applied Biocode
- Qiagen
- Curetis Gmbh
- Others
GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032
- Respiratory
- Gastrointestinal
- Central Nervous System
- Other Types Of Syndromes (Cuti And Stds)
GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Laboratories
- Others
GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Syndromic Multiplex Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Syndromic Multiplex Diagnostics Market Snippet by Type
2.1.2. Syndromic Multiplex Diagnostics Market Snippet by End Use
2.1.3. Syndromic Multiplex Diagnostics Market Snippet by Country
2.1.4. Syndromic Multiplex Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Syndromic Multiplex Diagnostics Key Market Trends
3.1. Syndromic Multiplex Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Syndromic Multiplex Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Syndromic Multiplex Diagnostics Market Opportunities
3.4. Syndromic Multiplex Diagnostics Market Future Trends
4. Syndromic Multiplex Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Syndromic Multiplex Diagnostics Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Syndromic Multiplex Diagnostics Market Landscape
6.1. Syndromic Multiplex Diagnostics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Syndromic Multiplex Diagnostics Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
7.1.2. Respiratory
7.1.3. Gastrointestinal
7.1.4. Central Nervous System
7.1.5. Other Types of Syndromes (cUTI and STDs)
8. Syndromic Multiplex Diagnostics Market – By End Use
8.1. Overview
8.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
8.1.2. Hospitals
8.1.3. Diagnostic Laboratories
8.1.4. Others
9. Syndromic Multiplex Diagnostics Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
9.2.1. Overview
9.2.2. Syndromic Multiplex Diagnostics Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Syndromic Multiplex Diagnostics Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3.7. France
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3.8. Italy
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3.9. Spain
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.9.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3.10. United Kingdom
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3.11. Russia
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3.12. Netherlands
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3.13. Sweden
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3.14. Poland
9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3.15. Rest of Europe
9.3.15.1. Overview
9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Syndromic Multiplex Diagnostics Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4.8. South Korea
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4.9. Japan
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Syndromic Multiplex Diagnostics Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Syndromic Multiplex Diagnostics Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10. Key Vendor Analysis- Syndromic Multiplex Diagnostics Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.2. Thermo Fisher Scientific, Inc.
10.2.3. F. Hoffmann-La Roche Ltd
10.2.4. Qiagen
10.2.5. bioMérieux
10.2.6. DiaSorin S.p.A (Luminex Corporation)
10.2.7. Hologic, Inc.
10.2.8. Becton, Dickinson and Company (BD)
10.2.9. Applied BioCode
10.2.10. QIAGEN
10.2.11. Curetis GmbH
10.2.12. Others
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
